Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Net Income: 2010-2025

Historic Net Income for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Sep 2025 value amounting to $30.1 million.

  • Arrowhead Pharmaceuticals' Net Income rose 109.30% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.1 million, marking a year-over-year increase of 104.93%. This contributed to the annual value of $30.1 million for FY2025, which is 104.94% up from last year.
  • Arrowhead Pharmaceuticals' Net Income amounted to $30.1 million in FY2025, which was up 104.94% from -$609.7 million recorded in FY2024.
  • Arrowhead Pharmaceuticals' 5-year Net Income high stood at $30.1 million for FY2025, and its period low was -$609.7 million during FY2024.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Net Income value was -$209.3 million (recorded in 2023), while the average stood at -$263.0 million.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 191.34% in 2024, then surged by 104.94% in 2025.
  • Arrowhead Pharmaceuticals' Net Income (Yearly) stood at -$140.8 million in 2021, then dropped by 25.31% to -$176.5 million in 2022, then dropped by 18.57% to -$209.3 million in 2023, then plummeted by 191.34% to -$609.7 million in 2024, then surged by 104.94% to $30.1 million in 2025.